Arthroscopic shoulder surgery
Conditions
Interventions
Group SA:Ultrasond-guided suprascapular nerve + axillary nerve block (0.5% bupivacaine 5ml+5ml)
Group I:Ultrasound-guided intermuscular sulcus brachial plexus (0.5% bupivacaine 10ml)
Sponsors
Wuxi 9th Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. 18 <=age; 2. Both sexes; 3. Complete the operation under conventional general anesthesia 4. ASA < III; 5. 18kg/m2 < BMI < 30 kg/m2; 6. Informed consent, voluntary participation in the trial, and signed by the informed consent.
Exclusion criteria
Exclusion criteria: 1. The operation time is expected to be > 3 hours; 2. The subject has serious communication difficulties caused by severe hearing degradation and other reasons; 3. Other drugs (such as intraoperative analgesics or sedatives, etc.) besides the preoperative preparation plan, anesthesia plan and normal saline are expected to be used for various reasons; The presence of poorly controlled atrial fibrillation before operation is expected to cause rapid ventricular rate atrial fibrillation during operation, which requires drug treatment, etc.); 4. Pregnant or lactating women; 5. The subject has a history of severe motion sickness and severe vertigo; 6. Conditions that failed to pass the preanesthesia visit (e.g., subjects with unsatisfactorily controlled hypertension, sitting systolic blood pressure >=180 mmHg, and/or diastolic blood pressure >=110 mmHg; Allergic to opioids and other experimental drugs and their drug components; Active phase of asthma; New myocardial infarction within 6 months; New cerebral infarction within 3 months; Obvious respiratory dysfunction, breathing air SpO2 40% white wine /150ml wine); 8. The subject explicitly refuses to participate in this study; 9. Participated in clinical trials of other drugs or devices within 3 months before the screening period; 10. Subjects deemed unfit to participate in this study by the researcher; 11. The subject does not eluate or take prohibited drugs as indicated in the standard; 12. The subject is unable to specify the name of the drug he/she has taken in the past 7 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog scale, VAS;Incidence of hemiphrenic paralysis;Hand grip strength monitoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| Opioid consumption;Anesthesia recovery time and extubation time;The amount of tramadol used for remedial analgesia within 48 hours after surgery; | — |
Countries
China
Contacts
Public ContactMeng Wang
Wuxi 9th Affiliated Hospital of Soochow University
Outcome results
None listed